GlassScriptPhysician profile
Brian M Brausa
NPI 1659411619
$3,551.60
in general payments reported to CMS, 2019-2025
21 companies · $1,735 in 2025
The $1,735 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $258 · 2021: $89.38 · 2022: $320 · 2023: $468 · 2024: $576 · 2025: $1,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813 · Travel and Lodging: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.32 |
| Travel and Lodging | $965.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,350.33 | 2024-2025 | |
| Organogenesis INC. | $658.32 | 2021-2025 | Puraply, Cygnus Dual, Puraply Wound Matrix |
| Smith+Nephew, INC. | $340.31 | 2020-2023 | Stravix, Pico, Renasys Go V2 Home |
| Horizon Therapeutics Plc | $288.51 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $138.07 | 2024-2025 | Diamondback Peripheral |
| Convatec INC. | $126.72 | 2020-2024 | |
| Abbvie INC. | $117.87 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $81.28 | 2022-2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $73.01 | 2024-2025 | Nuzyra |
| Bioventus LLC | $54.44 | 2022-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $54.06 | 2023-2025 | |
| Depuy Synthes Sales INC. | $48.05 | 2025 | Na |
| Globus Medical, INC. | $40.10 | 2025 | Senza |
| Amgen INC. | $29.59 | 2025 | Krystexxa |
| Merck Sharp & Dohme LLC | $25.03 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $24.58 | 2025 | Urgoclean Ag |
| Ani Pharmaceuticals, INC. | $24.39 | 2025 | Purified Cortrophin Gel |
| Surgenex LLC | $22.91 | 2025 | Renograft, Pellograft, Surgraft |
| Next Science LLC | $22.56 | 2023 | Blastx, Xperience, Surgx |
| Nevro Corp. | $17.49 | 2024 | Senza |
| Zak Ortho | $13.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Brausa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.